MiR-128-3p promotes the progression of deep venous thrombosis through binding SIRT1

Jinan Han1, Wanjiang Hao2, Yanping Ma3

  • 1Department of Vascular Surgery, Hulunbuir People's Hospital, Hulunbuir, China.

Phlebology
|July 19, 2023
PubMed
Abstract

Insights

MicroRNA-128-3p (miR-128-3p) impacts deep venous thrombosis (DVT) by targeting SIRT1. Upregulated miR-128-3p in DVT patients suggests its potential as a diagnostic biomarker.

Area of Science:

  • Vascular Biology
  • Molecular Medicine
  • Biomarker Discovery

Background:

  • Deep venous thrombosis (DVT) is a significant vascular condition.
  • Understanding the molecular mechanisms underlying DVT is crucial for diagnosis and treatment.
  • MicroRNAs play regulatory roles in various cellular processes relevant to thrombosis.

Purpose of the Study:

  • To investigate the role of microRNA-128-3p (miR-128-3p) in the pathogenesis of deep venous thrombosis (DVT).
  • To explore the relationship between miR-128-3p and its potential target, silent information regulator sirtuin 1 (SIRT1).
  • To evaluate the diagnostic potential of miR-128-3p in DVT patients.

Main Methods:

  • Cellular assays including MTT, Transwell, and flow cytometry were employed.
  • Luciferase activity assays identified the interaction between miR-128-3p and SIRT1.
  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) measured miR-128-3p and SIRT1 mRNA levels.
  • Receiver operating characteristic (ROC) curve analysis assessed the predictive value of miR-128-3p in DVT.

Main Results:

  • Reduced miR-128-3p expression promoted human umbilical vein endothelial cell (HUVEC) proliferation and migration while inhibiting inflammation, apoptosis, and adhesion.
  • The effects of miR-128-3p on HUVECs were mediated through targeting SIRT1.
  • miR-128-3p was found to be upregulated in patients with DVT and showed significant diagnostic capability.

Conclusions:

  • Overexpression of miR-128-3p plays a role in DVT development.
  • miR-128-3p demonstrates potential as a diagnostic biomarker for DVT patients.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
13
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K